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                                                                                         Introduction
INTRODUCTION
           The kidneys  are  a  pair  of  organs  that  are  primarily responsible  for  filtering
metabolites and minerals from the circulatory system. These secretions are passed to the
bladder and out of the body as the urine. [1]
Each kidney is enclosed in a fibrous capsule and is composed of a cortex and an inner
medulla.
The functional units of the kidney called nephrons, with in the cortex and medulla,
filters the blood under pressure and then reabsorb water and selected substance back in to the
blood. Approximately 1.0 – 1.5 million nephrons were packed in the average human kidney.
The urine thus formed is conducted from the nephrons via the renal tubules into the
renal pelvis and from there to ureter, which leads to the bladder. Two basic types of nephrons
can be distinguished,
1. Cortical nephrons               -      85%
2. Juxtamedullary nephrons  -     15%
Figure. No: 1 Anatomy of kidney
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The sole function of the urinary tract is the transmission and storage of urine. The
urinary tract consists of the minor and major calyces, renal pelvis, ureters, urinary bladder
and urethra.
                          RENAL DISEASES 
Renal diseases are classified into the six different physiological categories.
1. Acute Renal Failure (ARF) 
A sudden  decline  in  kidney  function  occurs  in  patients  with  pre-existing  renal
impairment is called Acute Renal Failure. ARF can be diagnostically classified into prerenal,
intrarenal and postrenal failure. [2, 3]
2. Chronic Renal Failure (CRF) (4)
         CRF is due a number of processes leading to permanent loss of kidney, function. Its
primary causes are high blood pressure and diabetes, but it can also be due to urinary tract
obstruction and kidney abnormalities, like polycystic kidney disease.
             Causes of CRF includes:        1) Chronic glomerulonephritis
                                                            2) Hypertension
                                                            3) Chronic pyleonephritis
                                                            4) Urinary obstruction
                                                            5) Congenital abnormalities
                                                            6) Metabolic abnormalities
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3. Hypertensive Kidney Disease
 Patients with severe hypertension cause renal lesions that diminish the blood flow or
diminished glomerular filteration per nephron.
4. The Nephrotic syndrome
       Nephrotic syndrome is a disease, which is characterized especially by loss of large
quantities  of  plasma  proteins  through  the  urine.  Protein  loss  is  due  to  increased
permeability of glomerular membrane. 
5. Specific Tubular Disorders
      They can cause abnormal reabsorption or lack of reabsorption of certain substances
by the tubules. If any required gene is absent or abnormal, then tubules might be deficient
of one particular enzyme or carrier. This leads to different tubular disorder.
6. Drug Induced Renal Disease
       Drug - induced kidney failure is a major adverse event associated with multiple
medication classes. The kidney is  particularly vulnerable to drugs and other agents that
cause renal damage (nephrolithiasis).  Medicatins as diverse as OTC analgesics (ibuprofen,
acetaminophen), antibiotics and chemotherapeutics agents can cause kidney damage.      
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NEPHROTOXICITY
 Nephrotoxicity can be defined as renal disease or dysfunction that arises as a direct or
indirect  result  of  exposure  to  medicines,  and  industrial  or  environmental  chemicals.  Drug
nephrotoxicity is therefore any renal dysfunction attributable to drugs. . Nephrotoxicity may
also be referred to as renal toxicity Nephrotoxicity is one of the most common kidney problems
and occurs when your body is exposed to a drug or toxin that causes damage to your kidneys.
When kidney damage occurs,  it’s  unable to  rid  body of  excess  urine,  and wastes.   Blood
electrolytes  (such  as  potassium  and  magnesium)  will  all  become  elevated.  It  produces  a
temporary elevation of Blood urea Nitrogen (BUN) and/or creatinine levels. Early diagnosis is
critical; therefore, physicians must be aware of the nephrotoxic potential of the medications
they prescribe and the risk status of their patients. [5,6]
       Figure. No: 2 Drug Induced Nephrotoxicity
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Nephrotoxicants may act at different sites in the kidney, resulting in altered renal function. The
sites of injury by selected nephrotoxicants are shown.
 Nonsteroidal  anti-inflammatory  drugs  (NSAIDs),  angiotensin-converting  enzyme
(ACE)  inhibitors,  cyclosporin  A,  and  radiographic  contrast  media  cause
vasoconstriction.
 Gold, interferon-alpha, and penicillamine can alter glomerular function and result in
proteinuria  and  decreased  renal  function.  Many  nephrotoxicants  damage  tubular
epithelial cells directly. 
 Aminoglycosides, cephaloridine, cadmium chloride, and potassium dichromate affect
the S1 and S2 segments of the proximal tubule, whereas cisplatin, mercuric chloride,
and dichlorovinyl-L-cysteine affect the S3 segment of the proximal tubule.
 Cephalosporins,  cadmium chloride,  and NSAIDs cause interstitial  nephritis  whereas
phenacetin causes renal papillary necrosis.
 Brief Histology and Physiology:
                  The nephron is the functional unit of the kidney and consists of a continuous tube of
highly  specialized  heterogeneous  cells,  which  show sub-specialization  along  the  length  of
nephrons and between them. It  is the major organ of excretion and homeostasis for water-
soluble  molecules;  because  it  is  a  metabolically  active  organ,  it  can  concentrate  certain
substances  actively.  In  addition,  its  cells  have  the  potential  to  bio  convert  chemicals  and
metabolically activate a variety of compounds. 
                      Since the kidney excretes many drugs, it is routinely exposed to high
concentrations of these drugs or their metabolites or both. Furthermore, the kidney has several
features that allow nephrotoxins to accumulate. It is highly vascular, receiving about 25% of
the resting cardiac output. The proximal renal  tubule presents a large area for nephrotoxin
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binding  and  transport  into  the  renal  epithelium.  Reabsorption  of  the  glomerular  filtrate
progressively  increases  intraluminal  nephrotoxin  concentrations,  while  specific  transport
pathways in the kidney may engender site-specific toxicity.
Nephrotoxicity Induced Oxidative Stress:
Nephrotoxicants are generally thought to produce cell injury and death through one of
two mechanisms, either alone or in combination. In some cases the toxicant may have a high
affinity for a specific macromolecule or class of macromolecules that result in altered activity
(increase or  decrease)  of  these  molecules,  resulting in  cell  injury.  Alternatively,  the parent
nephrotoxicant may not be toxic until it is bio transformed into a reactive intermediate that
binds covalently to macromolecules and in turn alters their activity, resulting in cell injury.
Finally, the toxicant may increase reactive oxygen species in the cells directly, after being bio
transformed into a reactive intermediate or through redox cycling. The resulting increase in
reactive oxygen species results in oxidative damage and cell injury. [7,8]
Chart. No.1: Nephrotoxicity Induced Oxidative Stress.
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MECHANISMS OF TOXICITY:
Many  drugs  can  injure  the  kidney  but  they  cause  renal  injury  via  only  a  few
mechanism. Renal injury can be in the form of  acute renal failure,  nephrotic syndrome,
chronic renal failure & renal tubular toxicity.[9]
I. ACUTE RENAL FAILURE 
              Drugs can cause acute renal failure by three mechanisms: 
1. Pre-renal 
2. Intrinsic 
3. Obstructive. 
1. Pre-Renal:
Some drugs can cause acute renal  failure  by reducing the volume or
pressure  or  both  of  blood  delivered  to  the  kidney;  the  resulting  renal  failure  is
therefore  termed  “prerenal.”  Patients  at  risk  are  those  who  already  have
compromised renal blood flow such as with bilateral renal artery stenosis, or with
decreased  effective  circulatory volume as  with  cirrhosis,  nephrotic  syndrome,  or
congestive  heart  failure.  Because  of  hypovolemia,  urine  volume  and  sodium
excretion are low while osmolality is high. The urine sediment is usually without
casts, red blood cells and white blood cells. 
2. Intrinsic/renal:
Three types of intrinsic acute renal failure exist: 
A. Acute tubular necrosis 
B. Acute interstitial nephritis 
C. Thrombotic microangiopathy 
A. Acute Tubular Necrosis:
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Mechanisms of injury are multiple but  may overlap,  including direct  tubular
toxicity,  deranged  cellular  energy  production,  free  radical  injury  heme  tubular
toxicity, abnormal phospholipid metabolism, and intracellular calcium toxicity. [10]
B. Acute interstitial nephritis:
Acute  interstitial  nephritis  presents  with  systemic  manifestations  of  a
hypersensitivity reaction such as fever,  rash,  and arthralgias.  Although penicillins
and cephalosporins are well-recognized culprits, almost any antibiotic can cause it
occasionally. The fluoroquinolone ciprofloxacin is now a well-recognized cause of
allergic interstitial nephritis.[11, 12]
           Urinary findings include white blood cells, red blood cells, and white cell
casts.  The  major  histologic  findings  are  interstitial  edema  and  variable  cellular
infiltration by eosinophils, plasma cells, T lymphocytes, monocytes, and neutrophils.
In rare cases, granulomas may be seen on kidney biopsy; patients with granulomas
may also present with uveitis. In most cases, acute interstitial nephritis is reversible
when the offending agent is stopped.
C. Thrombotic microangiopathy:
              Thrombotic microangiopathy can cause severe acute renal failure. In
general, the pathologic hallmark of thrombotic microangiopathy is hyaline thrombi
in  the  microvasculature  of  many organs.  Changes  in  the kidney include afferent
arteriolar and glomerular thrombosis and thickening of the glomerular capillary wall
on electron microscopy due to the deposition of fibrin-like materials. Thrombotic
microangiopathy  may manifest  with  fever,  hemolytic  anemia,  thrombocytopenia,
renal dysfunction, and central nervous system disease —thrombocytopenic purpura
(TTP)  most  frequently  seen  in  adults.  Urinalysis  shows  microscopic  hematuria,
subnephrotic proteinuria, hyaline, and few granular casts. The reticulocyte count is
elevated, haptoglobin levels are low, schistocytes are present in the peripheral blood
smear, and the lactate dehydrogenase level is high.  Overall mortality is high, though
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many patients may survive on chronic dialysis. Steroids are of no proven benefit in
this syndrome. 
2. Obstructive:
Drug-associated  obstruction  of  urine  outflow  can  occur  at  several  sites:
within the tubules or the ureters (due to crystal formation), and outside the ureters
(due  to  retroperitoneal  fibrosis  caused  by  agents  such  as  methysergide).[11] Risk
factors  for  crystal-induced  acute  renal  failure  include  severe  volume  depletion
underlying renal insufficiency, bolus drug administration,  and metabolic disorders
such as metabolic acidosis or alkalosis. The urine sediment may contain red cells,
white cells, and crystals. 
II. Nephrotic Syndrome:
The nephrotic syndrome is due to glomerular dysfunction and marked by heavy
proteinuria. Drugs implicated include gold, NSAIDs, penicillamine, interferon, and
captopril.  Patients  may  present  with  edema,  proteinuria,  and  hypoalbuminemia.
Membranous  nephropathy  is  the  most  common  form  reported,  though  minimal
change nephropathy has also been seen with NSAIDs, as discussed below. 
III. Chronic Renal Insufficiency :
Chronic  renal  insufficiency  caused  by  drugs  generally  presents  as
tubulointerstitial  disease.  It  is  important  to  note  that  for  some  drugs  (e.g.,
cyclosporine, lithium), the mechanism of acute renal toxicity may be different from
that of chronic renal injury. Patients may present with slowly progressive elevation
of creatinine, with or without renal tubular dysfunction syndromes. These syndromes
may  manifest  as  renal  tubular  acidosis,  renal  potassium  wasting,  concentration
defects,  and  tubular  proteinuria.  These  syndromes  may also  occur  without  renal
failure. In some cases, the renal damage is reversible when the offending drug is
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stopped,  but  in  other  cases  it  is  irreversible.  Frequently reversible  forms include
those due to 5- aminosalicylic acid, 6 mesalamine, and ifosfamide, while lithium and
cyclosporine cause irreversible injury.
IV. Analgesic nephropathy:
Analgesic nephropathy, simply, is renal dysfunction caused by analgesics. It
may be a consequence of the excessive consumption of mixed analgesics or single
analgesic use. .  A variety of analgesics and NSAIDs have been shown to have the
potential to cause RPN and interstitial  nephritis.[13,14] The resultant lesions can be
recognized  by  radiological  examinations  or  ultrasonography  and  consist  of
calcifications along the line line of  Hodson, shrinking of the kidneys resulting in
irregular contours, and decreased length of both kidneys. Necrotic papillae may be
voided in the urine and this is occasionally observed.
V. Tubular Cell Toxicity
Renal tubular cells, in particular proximal tubule cells, are vulnerable to
the  toxic  effects  of  drugs  because  their  role  in  concentrating  and  reabsorbing
glomerular filtrate exposes them to high levels of circulating toxins.[15] Drugs that
cause tubular  cell  toxicity do so by impairing mitochondrial  function,  interfering
with  tubular  transport,  increasing  oxidative  stress,  or  forming  free  radicals.[16,17]
Drugs associated with this pathogenic mechanism of injury include aminoglycosides,
amphotericin B cisplatin, foscarnet and zoledronate.
 Other Causes Are:
 Inflammation
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 Crystal nephropathy
 Rhabdomyolysis 
 Altered intraglomerular Hemodynamics
 Thrombotic micro angiopathy
 Inflammation:
Drugs can cause inflammatory changes in the glomerulus, renal tubular cells,
and  the  surrounding  interstitium,  leading  to  fibrosis  and  renal  scarring.
Glomerulonephritis  is  an  inflammatory  condition  caused  primarily  by  immune
mechanisms  and  is  often  associated  with  proteinuria  in  the  nephrotic  range.15
Medications such as gold therapy, hydralazine,lithium, NSAIDs, propylthiouracil, and
pamidronate  have been reported as causative agents.[15,16,17]
Acute interstitial  nephritis,  which  can  result  from an  allergic  response to  a
suspected drug, develops in an idiosyncratic, non–dose-dependent fashion. Medications
that cause acute interstitial nephritis are thought to bind to antigens in the kidney or act
as antigens that are then deposited into the interstitium, inducing an immune reaction.
However,  classic  symptoms  of  a  hypersensitivity  reaction  (i.e.,  fever,  rash,  and
eosinophilia)  are  not  always  observed.[16,18] Numerous  drugs  have  been  implicated,
including allopurinol  Beta lactams antibiotics, quinolones, rifampin ,sulfonamides, and
vancomycin, acyclovir and loop diuretics  thiazides, NSAID omeprazole ,pantoprazole,
and lansoprazole.
 Crystal Nephropathy:
                  Renal impairment may result from the use of drugs that produce crystals that
are insoluble in human urine. The crystals precipitate, usually within the distal tubular
lumen, obstructing urine flow and eliciting an interstitial reaction.[13] The likelihood of
crystal  precipitation  depends on the  concentration  of  the  drug in  the  urine  and the
urinary  pH.[19] Patients  most  at  risk  of  crystal  nephropathy are  those  with  volume
depletion and underlying renal  insufficiency. Commonly prescribed drugs associated
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with production of crystals include antibiotics, ampicillin, ciprofloxacin sulfonamides
antivirals  acyclovir,  foscarnet,  ganciclovir  methotrexate;  and  triamterene  .
Chemotherapy for lymphoproliferative disease, leading to tumor lysis syndrome with
uric acid and calcium phosphate crystal deposition, has also been associated with renal
failure.[20]
 Rhabdomyolysis:
     Rhabdomyolysis is a syndrome in which skeletal muscle injury leads to lysis
of  the  myocyte,  releasing  intracellular  contents  including  myoglobin  and  creatine
kinase into the plasma. Myoglobin induces renal injury secondary to direct toxicity,
tubular  obstruction,  and  alterations  in  GFR.  Drugs  may  induce  rhabdomyolysis
directly secondary to a toxic effect on myocyte function, or indirectly by predisposing
the myocyte to injury. Clinical manifestations of rhabdomyolysis include weakness,
myalgia, and tea-colored urine.Statins are the most recognizable agents associated with
rhabdomyolysis.Many drugs of abuse, such as cocaine, heroin, ketamine ,methadone,
and  methamphetamine,  have  been  reported  to  cause  rhabdomyolysis.  Drugs  and
alcohol are causative factors in up to 81 percent of cases of rhabdomyolysis, and up to
50 percent of patients subsequently develop acute renal failure. [21-23]
 Thrombotic Microangiopathy:
In thrombotic microangiopathy, organ damage is caused by platelet thrombi
in the microcirculation, as in thrombotic thrombocytopenic purpura. Mechanisms of
renal  injury  secondary  to  drug-induced  thrombotic  microangiopathy  include  an
immune-mediated  reaction  or  direct  endothelial  toxicity.[24] Drugs  most  often
associated with this pathogenic mechanism of nephrotoxicity include antiplatelet
agents clopidogrel ,ticlopidine cyclosporine, mitomycin-C and quinine .
Most drugs found to cause nephrotoxicity exert toxic effects by one or more common
pathogenic mechanisms:
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Drug class/drug(s)                                                Pathophysiologic mechanism of renal
Acyclovir (Zovirax) Acute interstitial 
nephritis, crystal 
nephropathy
Nonsteroidal anti-inflammatory drugs Acute interstitial 
nephritis, altered 
intraglomerular 
hemodynamics, 
chronic interstitial 
nephritis, 
glomerulonephritis
Antihistamines
Diphenhydramine (Benadryl), doxylamine (Unisom) Rhabdomyolysis
Aminoglycosides Tubular cell toxicity
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Ganciclovir (Cytovene) Crystal nephropathy
Rifampin (Rifadin) Acute interstitial 
nephritis
Beta lactams (penicillins, cephalosporins) Acute interstitial 
nephritis, 
glomerulonephritis 
(ampicillin, penicillin)
Sulfonamides Acute interstitial 
nephritis, crystal 
nephropathy
Vancomycin (Vancocin) Acute interstitial 
nephritis
Cisplatin (Platinol) Chronic interstitial 
nephritis, tubular cell 
toxicity
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Methotrexate Crystal nephropathy
Mitomycin-C (Mutamycin) Thrombotic 
microangiopathy
Triamterene (Dyrenium) Crystal nephropathy
Cocaine, heroin, ketamine ,methadone, methamphetamine Rhabdomyolysis
Proton pump inhibitors
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Lansoprazole ,omeprazole, pantoprazole Acute interstitial 
nephritis
Diuretics
Loops, thiazides
CISPLATIN
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 Cisplatin  is  one  of  the  most  widely  used  and  most  potent  chemotherapy  drugs.
Cisplatin  (cis-diamminedichloroplatinum(II),  CDDP)  is  an  antineoplastic  drug  used  in  the
treatment of many solid-organ cancers, including those of the head, neck, lung, testis, ovary,
and breast. While toxicities include ototoxicity, gastro toxicity, myelosuppression, and allergic
reactions  [25,26] the main dose-limiting side effect of cisplatin is nephrotoxicity.[27,28,29]  20% of
patients receiving high-dose cisplatin have severe renal dysfunction.
 Cisplatin-DNA crosslinks cause cytotoxic lesions in tumors and other dividing cells .
In  rapidly dividing  cells,  such  as  those  in  cancers,  cross-linking can  further  induce  DNA
damage.  Mildly damaged DNA can be repaired,  whereas  extensive  DNA damage leads  to
irreversible  injury  and  cell  death.  Cisplatin  has  multiple  intracellular  effects,  including
regulating genes, causing direct cytotoxicity with reactive oxygen species, activating mitogen-
activated protein kinases, inducing apoptosis, and stimulating inflammation and fibro genesis.
These  events  cause  tubular  damage  and  tubular  dysfunction  with  sodium,  potassium,  and
magnesium wasting. Most patients have a reversible decrease in glomerular filtration, but some
have an irreversible decrease in glomerular filtration.
Renal manifestations of cisplatin treatment:
Cisplatin nephrotoxicity can present in a number of ways. However, the most serious
and one of the more common presentations is acute kidney injury (AKI) which occurs in 20–
30% of patients.
• Acute kidney injury (20–30%) 
• Hypomagnesemia (40–100%) 
• Fanconi-like syndrome 
• Distal renal tubular acidosis 
• Hypocalcemia 
• Renal salt wasting 
• Renal concentrating defect 
• Hyperuricemia 
• Transient proteinuria 
• Erythropoietin deficiency 
• Thrombotic microangiopathy 
• Chronic renal failure 
Cisplatin Uptake into Renal Cells:
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 Uptake of cisplatin is  mainly through the organic transporter  pathway.  Transporter
mediated uptake is likely the major pathway in renal cells.[30] The organic cation transporter
(OCT 2) is the critical transporter for cisplatin uptake in proximal tubules in both animals and
humans. Transport mediated by these membrane proteins is polyspecific, electrogenic, voltage-
dependent, bi-directional, pH-independent, and Na_-independent.Three isoforms of OCT have
been identified in humans. OCT2 is the main OCT in the kidney, OCT1 is the main isoform of
the liver, and OCT3 is widely expressed, especially in the placenta. Cisplatin is not transported
through human OCT1, which may help explain its organ-specific toxicity.  In  addition to a
transporter-mediated process, cisplatin enters the cell through passive diffusion. In addition, the
organic  cation  transporter  OCT2  (SLC22A2)  transports  cisplatin.  Cisplatin  was  shown  to
inhibit the uptake of other OCT2 substrates, consistent with the view that these substrates share
a common transport pathway. Two recent observations point to an important role for OCT2 in
mediating renal cisplatin uptake and toxicity. First, knockout of theOCT2 gene significantly
reduced  urinary  cisplatin  excretion  and  nephrotoxicity. Second,  a  nonsynonymous  single-
nucleotide polymorphism (SNP) in the OCT2 gene (rs316019) was associated with reduced
cisplatin-induced nephrotoxicity in patients.[35,36]
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Figure. No: 3 Cisplatin Uptake into Renal Cells
Renal accumulation of cisplatin:
The kidney accumulates cisplatin to a greater degree than other organs and is the major
route for its excretion. The cisplatin concentration in proximal tubular epithelial cells is about 5
times the serum concentration. The disproportionate accumulation of cisplatin in kidney tissue
contributes  to  cisplatin-induced  nephrotoxicity.[37,38]  Cisplatin  is  accumulated  by peritubular
uptake in both the proximal and distal nephrons.[39,40] The S3 segment of the proximal tubule
accumulates the highest concentration of cisplatin, followed by the distal collecting tubule and
the S1 segment in the proximal tubule. Cisplatin concentrations within the kidney exceed those
in blood suggesting an active accumulation of drug by renal parenchymal cells.
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RISK FACTORS FOR CISPLATIN NEPHROTOXICITY.
Increased risk
 Dose
 Frequency
 Cumulative dose
 Older age
 Female sex
 Smoking
 Hypoalbuminemia
 Pre-existing renal insufficiency (limited data in humans)
Decreased risk
 Diabetes (uncertain in humans)
 OCT2 polymorphisms[41,42]
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Cisplatin Metabolism:
         Conversion of cisplatin to nephrotoxic molecules in the proximal tubule cells is
required  for  cell  injury.  The  highest  concentration  of  cisplatin  is  found  in  cytosol,
mitochondria,  nuclei,  and  microsomes.  Studies  in  rats  and  mice  indicate  that  cisplatin
undergoes metabolic activation in the kidney to a more potent toxin. This process begins with
the formation of glutathione conjugates in the circulation, perhaps mediated by glutathione-S-
transferase.  As  the  glutathione-conjugates  pass  through  the  kidney,  they  are  cleaved  to
cysteinyl-glycine-conjugates  by  gamma  glutamyl  transpeptidase  (GGT)  expressed  on  the
surface of the proximal tubule cells. The cysteinyl-glycine-conjugates are further metabolized
to cysteine-conjugates by aminodipeptidases, also expressed on the surface of the proximal
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Patient-related factors:
                  Age, sex, race Previous renal insufficiency Specific diseases (diabetes mellitus, hypertension,
sickle cell disease,  multiple myeloma, proteinuric disease, SLE) Sodium-retaining states (cirrhosis,  heart
failure,  nephrosis)  Dehydration  and  volume  depletion  Acidosis,  potassium  and  magnesium  depletion
Hyperuricemia, hyperuricosuria Sepsis, shock Renal transplantation. 
Drug-related factors:
                 Inherent nephrotoxic potential Dose Duration, frequency, and form of administration Repeated
exposure.
Drug interactions:
                Combined or closely associated use of diagnostic or therapeutic agents with added or synergistic
nephrotoxic potential  (e.g.,  radiocontrast  agents,  aminoglycosides,  nonsteroidal  anti-inflammatory drugs,
cisplatin, angiotensin-converting enzyme inhibitors) 
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tubule cells. The cysteine-conjugates are transported into the proximal tubule cells, where they
are further metabolized by cysteine-S-conjugate beta-lyase to highly reactive thiols.[41-45]
Figure.No: 4 Cisplatin Metabolism.
The importance of cellular transport in mediating toxicity. Proximal tubular uptake of
inorganic  mercury is  thought  to  be the  result  of  the transport  of  mercuric  conjugates  (eg,
diglutathione  mercury conjugate  [GSH-Hg-GSH],  dicysteine  mercuric  conjugate  [CYS-Hg-
CYS]).  At the luminal  membrane,  GSH-Hg-GSH appears  to  be metabolized by (-glutamyl
transferase ((-GT) and a dipeptidase to form CYS-Hg-CYS. The CYS-Hg-CYS may be taken
up by an amino acid transporter. At the basolateral membrane, mercuric conjugates appear to
be  transported  by  the  organic  anion  transporter.  (-Ketoglutarate  and  the  dicarboxylate
transporter  seem  to  play  important  roles  in  basolateral  membrane  uptake  of  mercuric
conjugates. Uptake of mercuric-protein conjugates by endocytosis may play a minor role in the
uptake of inorganic mercury transport. PAH—para-aminohippurate.[46,47]
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Figure. No: 5 glutathione and cysteine conjugates cisplatin induced nephrotoxity.
This figure illustrates the renal proximal tubular uptake, biotransformation, and toxicity of 
glutathione and cysteine conjugates and mercapturic acids of haloalkanes and haloalkenes.[48-50]
 1. Formation of a glutathione conjugates within the renal cell (R-SG).
 2. Secretion of the R-SG into the lumen.
 3. Removal of the _-glutamyl residue (_-Glu) by _-glutamyl transferase.
 4. Removal of the glycinyl residue (Gly) by a dipeptidase. 
 5. Luminal uptake of the cysteine conjugate (R-Cys). Basolateral membrane uptake of R-SG
 6. R-Cys (7), and a mercapturic acid  (N-acetyl cysteine conjugate; R-NAC)
 8,9 Secretion of R-NAC into the lumen.
 10. Acetylation of R-Cys to form R-NAC.
 11. Deacetylation of R-NAC to form R-Cys.
 12. Biotransformation of the penultimate nephrotoxic species (R-Cys) by cysteine conjugate
    -lyase to a reactive intermediate (R-SH), ammonia, and pyruvate.
 13. Binding of the reactive thiol to cellular macromolecules (eg, lipids, proteins) and initiation 
of cell injury.
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 Cisplatin  can  form  monohydrated  complexes  by  hydrolytic  reactions.  The
monohydrated complex  is  more  toxic to  the  renal  cells  than  cisplatin  but  it  is  not  kidney
specific.  The normal low intracellular chloride concentrations promote its  formation. Using
hypertonic saline to reconstitute cisplatin can decrease the amount of monohydrated complex
formed.  This  approach  attenuates  nephrotoxicity  but  may  also  compromise  its  antitumor
activity.
Cellular Targets of Cisplatin:
           Platinum compounds are believed to mediate their cytotoxic effects through their
interaction with DNA (Figure 6). In an aqueous environment, the chloride ligands of cisplatin
are replaced by water molecules generating a positively charged electrophile. This electrophile
reacts with nucleophilic sites on intracellular macromolecules to form DNA, RNA, and protein
adducts. Cisplatin binds to DNA leading to the formation of inter- and intra-strand cross-links,
thereby arresting DNA synthesis and replication in rapidly proliferating cells. The finding that
cells deficient in DNA repair are more sensitive to cisplatin-induced cell death supports the
concept  that  cisplatin  mediates  its  anti-tumor  effects  through DNA damage.  However,  the
primacy  of  nuclear  DNA damage  as  the  cause  of  cisplatin-induced  cell  death  has  been
challenged. In fact, only a small amount of cellular platinum (<1%) is bound to nuclear DNA
and there is a poor correlation between the sensitivity of cells to cisplatin-induced cell death
and the extent of DNA platination Cisplatin is hydrolyzed to generate a positively charged
metabolite which preferentially accumulates within the negatively charged mitochondria. Thus,
the sensitivity of cells to cisplatin appears to correlate with both the density of mitochondria
and  the  mitochondrial  membrane  potential.  This  observation  may  explain  the  particular
sensitivity of the renal proximal tubule to cisplatin toxicity, as this segment exhibits one of the
highest densities of mitochondria in the kidney.[51,52]
Moreover,  depletion of mitochondrial  DNA by growth of cells in ethidium bromide
rendered  cells  highly  resistant  to  cisplatin.  Finally,  mitochondrial  DNA  may  be  more
susceptible than nuclear DNA to cisplatin-induced damage, due to less efficient DNA repair
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mechanisms. Taken together, these observations point to mitochondrial DNA as an important
target in cisplatin toxicity.
Figure.  No:  6  Pathways  of  cisplatin-induced  epithelial  cell  death.  Cisplatin  enters  renal
epithelial cells via the OCT2 and, to a lesser extent, Ctr1 transporters. Cisplatin causes damage
to nuclear and mitochondrial DNA and production of reactive oxygen species (ROS) which
lead to activation of  both mitochondrial  and non-mitochondrial  pathways  of  apoptosis  and
necrosis.[53-57]
   Mitochondrial  energetics  is  also  disrupted  by  cisplatin  and  may  contribute  to
nephrotoxicity. Fatty acids are the major source of energy for the proximal tubule, the primary
site of cisplatin kidney injury. Cisplatin inhibits fatty acid oxidation in mouse kidney and in
proximal tubule cells in culture through a reduction in PPAR-α mediated expression of genes
involved  in  cellular  fatty  acid  utilization.  Cisplatin  also  affects  mitochondrial  respiratory
complexes  and  function.  Exposure  of  cultured  proximal  tubule  cells  to  cisplatin  in  vitro
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inhibited mitochondrial complexes I to IV of the respiratory chain and, as a result, decreased
intracellular ATP levels. Cisplatin treatment in vivo also resulted in mitochondrial dysfunction
as evidenced by a decline in membrane electrochemical  potential, a substantial  decrease in
mitochondrial calcium uptake and depletion of mitochondrial antioxidant defense systems.
Biochemical changes in the renal cell:
Cisplatin induces specific gene changes. Cisplatin-induced nephrotoxicity is mediated
by mitogen-activated  protein  kinase  (MAPK) intracellular  signaling pathways.  The  MAPK
pathways are a series of  parallel  cascades of  serine/threonine kinases that  are activated by
diverse  extracellular  physical  and  chemical  stresses.  They  regulate  cell  proliferation,
differentiation, and survival.[58,59] The 3major MAPK pathways terminate in the extracellular
regulated  kinase  (ERK),  p38,  and  Jun  N-terminal  kinase/stress-activated  protein  kinase
(JNK/SAPK) enzymes. The ERK pathway is typically activated by extracellular growth factors
and has been linked to both cell survival and cell death. The p38 and JNK/SAPK pathways are
activated by a variety of stresses, for example, oxidants, UV irradiation, hyperosmolality, and
inflammatory cytokines;  they have been linked  to  cell  death.  ERK pathway contributes  to
proximal tubule injury is not clear, but certain responses in the distal nephron could induce
adjacent proximal tubule injury through autocrine and paracrine processes.[60-62] P38 activation
mediates proximal tubule cells injury.  Stimulation of p38 is mediated by hydroxyl radicals,
which  are  induced  by  cisplatin.  The  JNK/SAPK  pathway  in  the  cisplatin-induced
nephrotoxicity has not been well studied. Intracellular Events that Damage Renal Cells The in
vivo  mechanisms  of  cisplatin  nephrotoxicity  are  complex  and  involve  oxidative  stress,
apoptosis, inflammation, and fibrogenesis. High concentrations of cisplatin induce necrosis in
proximal tubule cells,  whereas lower concentrations induce apoptosis through a caspase-9–
dependent pathway.[63,64]
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Apoptotic pathways in cisplatin nephrotoxicity:
                  Apoptosis of renal tubular cells has been a focus of mechanistic investigation of
cisplatin nephrotoxicity.  Several pathways of apoptosis have been implicated,  including the
extrinsic pathway mediated by death receptors, the   pathway centered on mitochondria, and
the endoplasmic reticulum (ER)-stress pathway (Figure 7). In the extrinsic pathway, binding of
the death receptors by ligands at the plasma membrane leads to the recruitment and activation
of caspase-8, which further activate downstream caspases to induce apoptosis.[65] Major death
receptors include Fas,  tumor-necrosis factor-a (TNF-a) receptor (TNFR) 1 and importantly,
pharmacological  and  genetic  inhibition  of  TNF-a  attenuated  the  production  of  various
cytokines  and  chemokines,  which  was  accompanied  by  the  amelioration  of  cisplatin
nephrotoxicity.   TNF-a  in  the  inflammatory  response  and  cisplatin  nephrotoxicity,  it  is
suggested that TNFR2, and not TNFR1, is mainly responsible for the pathogenic signaling of
TNF-a TNF-a and its receptors may induce renal injury primarily by mounting a disastrous
inflammatory response rather than by directly activating the extrinsic pathway of apoptosis.
[66,67]
 On the other  hand,  the intrinsic or  mitochondrial pathway has emerged as the major
apoptotic pathway in cisplatin nephrotoxicity. In the intrinsic pathway, cellular stress leads to
the  activation of  the proapoptotic  Bcl-2 family proteins  Bax  and Bak,  which form porous
defects on the outer membrane of mitochondria, resulting in the release of apoptogenic factors
from the organelles. The apoptogenic factors released from mitochondria include cytochrome
c, AIF (apoptosis-inducing factor), Smac/DIABLO, endonuclease G, and others. Cytochrome
c, after being released into the cytosol, binds to and induces conformational changes in the
adaptor protein Apaf-1, leading to the recruitment and activation of caspase-9, which in turn
after proteolytic processing activates downstream caspases for caspase-dependent apoptosis.
Smac, after being released into cytosol, can bind and antagonize the caspase inhibitor proteins,
IAPs (inhibitor of apoptosis proteins) to further augment caspase activation. 
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Figure. No: 7 Apoptotic Pathways in Cisplatin Nephrotoxicity.
 Oxidative stress injury is actively involved in the pathogenesis of cisplatin-induced acute
kidney injury.
                  Reactive oxygen species (ROS) directly act on cell components, including lipids,
proteins, and DNA, and destroy their structure. ROS are produced via the xanthine-xanthine
oxidase system, mitochondria, and NADPH oxidase in cells. In the presence of cisplatin, ROS
are  produced  through  all  these  pathways  and  are  implicated  in  the  pathogenesis  of  acute
cisplatin-induced renal injury. First, once in a cell, cisplatin is aquated into a highly reactive
form, which can rapidly react with thiol-containing molecules including glutathinone, a well-
recognized  cellular  antioxidant.[68] Depletion  or  inactivation  of  glutathione  and  related
antioxidants  by  cisplatin  is  expected  to  shift  the  cellular  redox  status,  leading  to  the
accumulation of endogenous ROS and oxidative stress within the cells. Second, cisplatin may
induce mitochondrial dysfunction and increase ROS production via the disrupted respiratory
chain. Resulting in ROS generation. Paradoxically,  ROS formation under this situation was
dependent  on  residual  electron  flow  through  the  mitochondrial  respiratory  chain,  because
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complete inhibition of the respiration complexes blocked ROS accumulation. Finally, cisplatin
may  induce  ROS  formation  in  the  microsomes  via  the  cytochrome  P450  (CYP)  system.
Cisplatin induces glucose-6-phosphate dehydrogenase and hexokinase activity, which increase
free radical production and decrease antioxidant production.[69,70]
GUIDELINES TO PREVENTING DRUG-INDUCED NEPHROTOXICITY
In brief, the best clinical approach to drug-induced nephrotoxicity is prevention, which
starts with the recognition that drug-induced renal injury occurs and is seen predominantly in
patients at risk. The following steps are necessary: 
● Anticipate. Be aware of nephrotoxic potential of specific drugs. 
● Identify patients at risk.(those with renal insufficiency, dehydration, salt-retaining states, 
diabetes, and multiple myeloma). 
● Be aware of increased risk in elderly patients. 
● Carefully assess the benefits of prescribed drugs against potential risk. 
● Whenever possible, select diagnostic procedures or therapeutic measures without 
nephrotoxic potential. 
● Avoid dehydration mandatorily in high-risk patients. Pretreatment hydration is very 
important. 
● Limit total daily dosage and duration of treatment with certain drugs. 
● Adjust the daily dosage to ongoing alterations in the GFR. 
● Avoid a combination of potentially nephrotoxic drugs. 
● Urinary alkalinization to prevent renal failure from sulphonamides, methotrexate, 
triamterene, etc. 
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EXPERIMENTAL STRATEGIES TO PREVENT CISPLATIN
NEPHROTOXICITY
Reduced renal cisplatin accumulation or activation:
• OCT2 inhibitors, e.g., cimetidine or metformin.
• Ctr1 inhibitors, e.g., copper.
• Micellar/liposomal cisplatin.
• Gamma-glutamyl transpeptidase inhibitors.
• Glutathione transferase inhibitors.
Anti-oxidants:
 Amifostine.
 BNP7787.
 N-acetyl cysteine.
 Superoxide dismutase Catalase.
 Selenium and Vitamin E.
 Heme oxygenase-1 induction.
 Iron chelators, e.g., Desferoximine .
 Allopurinol plus ebselen .
 Milk thistle extracts (silymarin).
 Cannabidiol.
 Lycopene.
Anti-apoptosis:
 p53 inhibitors, e.g., pifithrin.
 HDAC inhibitors.
 Caspase inhibitors.
 P21agonists/CDK2 inhibitors.
Anti-inflammation:
 TNF-α antagonist.
 TLR4 antagonists.
 p38 inhibitors.
 JNK inhibitors Salicylates.
 PPAR-α ligands, e.g., fibrates.
 PPAR-γ ligands, e.g. rosiglitazone.
 Alpha lipoic acid.
 IL-10.

Treatment of cisplatin nephrotoxicity:
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There is no specific treatment for cisplatin-induced renal dysfunction or injury. These
patients need careful attention to hydration and electrolyte treatment.  They frequently need
magnesium and potassium replacement. Cisplatin and magnesium affect the same sodium and
water channels in the outer medulla. Cisplatin induces magnesium depletion, and magnesium
deficiency  itself  may enhance  cisplatin  nephrotoxicity.  Cisplatin  treatment  often  produces
extensive gastrointestinal side effects, which might lead to more magnesium depletion through
anorexia  and  diarrhea.  Therefore,  magnesium  repletion  may  attenuate  cisplatin-induced
nephrotoxicity.
Signal Transduction:
                 Serum thymic factor is a non apeptide thymic hormone isolated from the thymus and
is  involved  in  functional  activation  and  differentiation  of  T  cells.  Serum  thymic  factor
significantly ameliorates  sustained ERK activation and  induces  the  increased  level  of  heat
shock  protein  70,  which prevents  cisplatin-  induced renal  damage in  the  rat  model.  Other
selective MAPK/ERK inhibitors  have also been shown to attenuate cisplatin-induced renal
injury  by  decreasing  inflammation  and  apoptosis.  However,  because  cisplatin-induced
apoptosis  in  human  tumor  cells  is  mediated  by  MAPK/ERK activation,  inhibition  of  this
pathway may disturb the anti-tumor activity of cisplatin. [71,72]
Antioxidant Drugs:
                               The combination of allopurinol and ebselen reduces cisplatin-induced
nephrotoxicity and ototoxicity in a rat model. Allopurinol is a xanthine oxidase inhibitor with
the  potential  to  reduce  ROS  generation.  Ebselen,  a  glutathione  peroxidase  mimic,  is  an
excellent scavenger of peroxynitrite and can protect against lipid peroxidation in the presence
of glutathione or other thiols. Ebselen has excellent oral availability and has been evaluated in
human  clinical  testing  for  the  treatment  of  acute  ischemic  stroke..  Erdosteine  increases
glucose-6-phosphate  dehydrogenase  activity,  which  helps  maintain  the  proper  intracellular
redox state and protects against  oxidant stress.  Edaravone and  N-acetylcysteine can replete
intracellular stores of reduced glutathione. Other compounds with antioxidant property such as
silymarin, naringernin, vitamin C, and vitamin E have also been found to have renoprotective
function in animal studies. [73]
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Amifostine:
                    Amifostine, an organic triphosphate, may diminish cisplatin-induced toxicity by
donating a protective thiol group, an effect that is highly selective for normal but not malignant
tissue.  Amifostine  is  the  only  FDA-approved  agent  for  the  reduction  of  cumulative  renal
toxicity in advanced ovarian and non–small-cell lung cancer patients receiving cisplatin. This
drug limits toxicity by binding free radicals. It may also bind and detoxify platinum agents by
reduction of platinum-DNA adduct formation. [74]
Anti-inflammatory Drugs:
                 However, high doses of salicylates can stabilize I_B and reduce NF-_B transcription
activity,  and  these  effects  attenuate  TNF-_  production  and  reduce  renal  inflammation  in
cisplatin  toxicity  models.  This  may  be  explained  by  the  observation  that  cisplatin
nephrotoxicity is mediated via TNFR2, whereas the anti-tumor effect of TNF is mediated by
TNFR1. Moreover, inhibition of NF-_B, a cell survival factor, by salicylate might increase the
effectiveness of chemotherapy. [75]
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A. Sreedevi,  k.,  et  al.,  (2011) Examined the effect  of  petroleum ether,  ethyl  acetate and
alcoholic extracts of aerial parts of Vernonia cinerea (500 mg/kg, p.o.) on cisplatin-induced
nephrotoxicity (6mg/kg, i.p.) in albino rats. Prophylactic and curative effect was assessed by
estimating  blood  urea  nitrogen,  serum  creatinine,  serum  total  proteins,  urinary  protein,
creatinine clearance and urine to serum creatinine ratio. Among the three extracts, alcoholic
extract  showed  pronounced  curative  activity,  ethyl  acetate  extract  exhibited  good
prophylactic  activity  and  petroleum  ether  extract  showed  moderate  protection  in  both
curative and prophylactic models against cisplatin-induced toxicity.[76]
Sahar Khalil Abdel-Gawad, et al.,  (2010) Investigated whether  silymarin administration
protects against cisplatin-induced nephrotoxicity in adult male albino rats. This study was
performed  on  30  adult  male  albino  rats;  Biopsies  were  processed  for  light  microscopic
studies.  Immunohistochemical  expression of Bak protein was investigated.  In  observation
there was a decrease in the PAS +ve material at brush borders of the PCT and a positive
cytoplasmic  reaction  of  Bak  protein  in  renal  tubular  cells.  It  concluded  Silymarin
pretreatment  prevented  the  histopathological  changes  caused  by  cisplatin&  also  proved
Silymarin exert protecting effective against cisplatin-induced nephrotoxicity. [77]
El-Sayed el-sayed, et al., (2008) Investigated  captopril, an angiotensin-converting enzyme
(ACE) inhibitor containing sulfhydryl (-SH) group showed protecting effect against cisplatin-
induced nephrotoxicity in rats. In cisplatin induced toxicity, a significant increase in blood
urea nitrogen (BUN) and creatinine levels and marked elevation in lipid peroxides measured
as malondialdehyde (MDA), accompanied by a significant decrease in reduced glutathione
(GSH) as compared to control group. In addition marked increase in kidney tissue content of
nitric oxide (NO) and plasma endothelin-1(ET-1). Result indicated captopril, an ACEI, has a
protective effect against cisplatin-induced damage to kidney. That it may relate to its free
radicals scavenging and antioxidant effects which are sulfhydryl dependent. [78]
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SarawootPalipoch, et al., (2013) Investigated the possible protective role of curcumin and
α-tocopherol  against  cisplatin  induced  nephrotoxicity  in  rat.  Serum  blood  urea  nitrogen
(BUN),  creatinine  and  malondialdehyde (MDA) levels,  superoxide  dismutase  (SOD) and
catalase  activities,  kidney  histopathological  study  and  gene  expressions  of  nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase and p38 mitogen activated protein kinase
(p38-MAPK) were investigated  Pre-treatment with combined curcumin and α-tocopherol
exhibited significantly reduced MDA levels and enhanced activities of SOD and catalase
compared with cisplatin-treated group (p < 0.05). It also improved BUN as well as creatinine
levels  and  kidney histopathology.  Moreover,  gene  expressions  of  NADPH oxidase  were
decreased,  whereas  p38-MAPK  gene  expressions  were  not  significant  compared  with
cisplatin-treated  group.  In  conclusion  combined  curcumin  and  α-tocopherol  are  able  to
reduce cisplatin-induced nephrotoxicity via possible inhibition of NADPH oxidase, resulting
in improvement of kidney function and histology.[79]
GholamrezaKarimi, et al.,(2009) Demonstrated protective effect of aqueous and ethanolic
extracts of  portulacaoleracea  against  cisplatin induced nephrotoxicity in rats. Blood urea
nitrogen (BUN) and serum creatinine (Scr) concentration were determined. Morphological
renal  damage was evaluated.  Results indicated that  treatment with aqueous and ethanolic
extracts of P. oleracea in cisplatin induced toxicity reduced BUN and Scr. Tubular necrotic
damage was not observed. It  concluded P.  oleracea  extract  may protect  against  cisplatin-
induced renal toxicity and might serve as a novel combination agent with cisplan to limit
renal injury.[80]
Annie shirwaikar, et al., (2003) Studied protective role of Ethanolic extract of flowers of
pongamiapinnata against  cisplatin  and  gentamicine  induced  renal  injury  in  rats.  Body
weight,  blood urea and serum creatinine was observed. Extract  at  the dose of 600mg/kg
normalized  the  raised  blood  urea  and  serum  creatinine  levels  in  histopathological
examination  reversal  of  cisplatin  and  gentamicine  renal  cell  damage  as  induced  tubular
necrosis,  marked  congestion  of  the  glomeruli  with  glomerular  atrophy,  degeneration  of
tubular epithelial cells with casts in the in the tubular lumen and infiltration of inflammatory
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cells in the interstitium were confirmed. In addition ethanolic extract of flowers had a marked
nitric oxide free radical scavenging suggesting an anti-oxidative property.[81]
Salma Khanametal, et al., (2011) Investigated the importance of Tinospora cordifolia stem
extract  for  its  possible  curative  effect  in  male  wistar  rats  against  the  cisplatin  induced
nephrotoxicity. There was an increase in serum creatinine, blood urea nitrogen and alkaline
phosphatase in rats treated with Cisplatin. Administration of Cisplatin followed by alcoholic
extract of Tinospora cordifolia decreased the increased levels of serum creatinine, blood urea
nitrogen  and  alkaline  phosphatase  in  rats.  These  biochemical  observations  were
supplemented  by  histopathological  examination  of  kidney  section.  Results  of  this  study
revealed that the alcoholic stem extract of  Tinospora cordifolia  has curative action against
Cisplatin induced nephrotoxicity.[82]
Amr A. Fouadetal, et al., (2010) Investigated nephroprotective effect of coenzyme Q10 in
mice with acute renal injury induced by a single i.p. injection of cisplatin. Coenzyme Q10
treatment  was  applied  for  6  consecutive  days,  1  day  before  cisplatin  administration.
Coenzyme Q10 significantly reduced glutathione level  and superoxide dismutase activity,
suppressed  lipid  peroxidation,  decreased  the  elevations  of  tumor  necrosis  factor  nitric
oxideand platinumion concentration, and attenuated there ductions of selenium and zinc ions
in renal tissue resulted from cisplatin administration. Histopathological renal tissue damage
mediated by cisplatin was ameliorated by coenzymeQ10 treatment.  Immunohistochemical
analysis  revealed  that  coenzymeQ10  significantly  decreased  the  cisplatin-induced
overexpression  of  inducible  nitric  oxide  synthase,  nuclear  factor-  B,  caspase-
3andp53inrenaltissue It was concluded that coenzyme Q10 represents a potential therapeutic
option to protect against acute cisplatin nephrotoxicity in clinical practice.[83]
N.sheena,  etal,.  (2003) Evaluated  the  preventive  effect  of  the  methanolic  extract  of
G.Lucidum  to  ameliorate  cisplatin-induced  nephrotoxicity  in  mice.  Nephrotoxicity  was
assessed      by determining the serum creatinine and urea levels and renal antioxidant status
in mice after cisplatin administration Methanolic extract of  G.lucidum given  orally before
cisplatin injection. The extract significantly reduced the elevated serum creatinine and urea
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levels.  Renal  antioxidant  defense  systems,  such  as  superoxide  dismutase,  catalase,
glutathione peroxidase activities and reduced glutathione level, depleted by cisplatin therapy
were restored to normal by treatment with the extract. Cisplatin-induced lipid peroxidation
was  found  markedly  reduced  by  treatment  with  the  extract.  The  results  indicated  that
methanolic  extract  of  G. lucidum  rendered  significant  preventive effect  against  cisplatin-
induced nephrotoxicity. The findings suggest the potential therapeutic use of South Indian G.
lucidum in cancer chemotherapy. [84]
Kundan, G.,inganle, et al., (2013) Evaluated the nephroprotective effective of methanolic
extract of hygrophila spinosa (HSME) in cisplatin induced acute renal failure in rats .HSME
were a dministered orally to male wistar rats,  the parameters glutathione (GSH), catalase
(CAT),  superoxide  dismutase  (SOD)and  GSH  peroxidase  activities  .  histopathological
examination  was  carried  out.  The  result  revealed  that  HSME  pretreatment  significantly
reduced blood urea and also attenuated cisplatin induced increase in MDA and decrease in
reduced  GSH  and  CAT  and  SOD  and  GSH  peroxidase  activites  in  renal  cortical
homogenates.  Histopathological  examination  showed  that  HSME  marked  ameliorated
cisplatin induced renal tubular necrosis.It  concluded that the aerial parts of  H.spinosa are
endowed with nephroprotective activity.[85]
Salman  khan  M,  et  al.,  (2013) Investigated  chemotherapeutic  potential  of  Boerhaavia
diffusa linked from ancient time to the present with the scope in future. Furthermore a recent
update on mechanistic approaches of B. diffusa has also been discussed. Based on antioxidant
&  antdiabetic  characteristic  it  is  hypothesized  that  Boerhaavia  diffusa might  exhibit
antiglycating properties as well.[86]
Kanjoormana  Aryan  Manu,  et  al.,  (2009) Evaluated  Immunomodulatory  activities  of
punarnavine,  an  alkaloid  from  B.  diffusa using  Balb/C  mice.  Punarnavine  enhanced
proliferation of splenocytes, thymocytes and bone marrow cells both in presence and absence
of  specific  mitogens  in  vitro  and  in  vivo.  More  over  administration  of  Punarnavine
significantly reduced the LPS induced elevated levels of pro inflammatory cytokines such as
TNF-α, IL-1β and IL-6 in mice. [87]
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Mandeepkaur, et al., (2009) Investigated the methanolic extract of Boerhaavia diffusa roots
& its different fraction including liriodendrin rich fraction for exploring the possible role of
liriodendrin  rich  in  its  anticonvulsant  activity.  These  finding  concluded  that  observed
anticonvulsant activity was due to calcium channel antagonistic action as this activity was
retained only in liodendrin rich fraction which posse’s significant anticonvulsant activity of
liriodendrin in BAY K-8644 induced seizures.[88]
Sandhya.k, et al., (2010) Had conducted a comparative study of hydro alcoholic extract and
poly  herbal  formulation  of  Boerhaavia  diffusa for  their   anti-stress  activity  using  cold
restrainst  stress  model.  Due to  cold  restrain  stress  there  was  imbalance  in   the  level  of
biochemical parameter like glucose, triglycerides, cholesterol, SGOT, SGPT which were near
normalized following the administration of HAEBD &  PHF-09. HAEBD and PHF-09 were
found to have comparable anti stress activity.[89]
Surendar. k. Pareta, et al., (2011) Found out the effects of pretreatment of aqueous extract
of  Boerhaavia  diffusa root  (200-400  mg/kg  /day)  in  repeated  dose  acetaminophen
nephrotoxic  rats  for  14  days.  Acetaminophen  administration  characterized  by  significant
increase  in  Blood  urea  nitrogen  (BUN),  serum creatinine  and  increased  level  of  kidney
malondialdehyde  proleinthiol,  along  with  depletion  of  SOD,  CAT,  GPX  and  GSH.
.Histopathological  changes  showed  significant  structural  damage  to  kidney.  The  result
suggest that  Boerhaavia diffusa has the potential in preventing the acetaminophen induced
Nephrotoxicity.[90]
Ramachandran. y. L, et al., (2011) Evaluated the hepatoprotective properties of petroleum
ether extract, Methanolic extract and isolated compound of  B. diffusa & A. lanata against
carbon tetra chloride induced hepatic damage in rats. This study reveals that different dose of
plant extract offer significant protection of serum test and liver histology.[91]
Shisode. k.s, et al., (2011) Had studied that different extract of roots of Boerhaavia diffusa
for  invitro  antioxidant  activities  &  phytochemical  screening.  Among these  there  extract,
ethanolic extract had shown better antioxidant activity & phytochemical screening revealed
the presence of carbohydrate saponins, proteins, flavonoids, steroids, fats & alkaloid. [92]
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Gopal. T.k, et al., (2010) Evaluated invitro antioxidant activities of chloroform, ethanol &
ethyl acetate fraction of B. diffusa.L which might have improved it’ hepatoprotective action.
The extract found to have significant nitric oxide and DPPH radical scavenging activity. The
result suggest  that roots of  Boerhaavia diffusa were found to reveal antioxidant potential
which support the use of plant in traditional medicine.[93]
ApurbasarkerApu.  et  al.,  (2012) Investigated  the  bioactivities  of  crude  n-hexane,  ethyl
acetate  and  methanolic  extract  of  aerial  parts  of  the  Boerhaavia  diffusa linn  and  its
phytochemical  analysis.  Methanolic  extracts  showed  higher  antioxidant,  thrombolytic
activity  and  less  cytotoxic  activity  than  that  of  n-hexane  &  ethyl  acetate  extract  of
Boerhaavia diffusa.  All  the extract  showed significant  inhibitory activity against  candida
albicans at  a  concentration  of  1000µg/disc.  These  findings  suggest  that  plant  could  be
important source of medicinally important natural compound.[94]
ShuklaAnamik,  Gupta  Rakeshkumar,  (2011) Studied  the  effects  of  aqueous  extract  of
Boerhaavia diffusa roots and leaves on blood sugar level is alloxan induced diabetic rats.
These studies conclude that aqueous extract of  B. diffusa have shown hypoglycemic effect
may be due to presence of glycosides, flavonoids, tannins and saponin in the extract. [95]
Suralkas  A.A et  al.,  (2012) Investigated  antihistamine  activity  of  ethanolic  extract   of
Boerhaavia  diffusa linn  roots  using  isolated  goat  tracheal  chain  and  histamine  induced
bronchoconstriction in Guinea pig Boerhaavia diffusa significantly inhibited dose dependent
contraction  of  goat  tracheal  chain  produced  by  histamine  and  also  showed  significant
protection by prolonging pre convulsion dyspnoea time in guinea pigs.  Thus  Boerhaavia
diffusa showed antihistaminic  and  broncho  dilating  activity  against  histamine  and  hence
posses potential role in treatment of asthma.[96]
Surendran. k, et al., (2010) Evaluated anti urolithiatic activity of Boerhaavia  diffusa linn
root aqueous extract and rationalize its use in treating renal stone. The lithogenic treatment
causes weight loss, hyperoxalurea and impairment of renal function. Boerhaavia diffusa linn
causes  diuresis  and  hasten  the  process  of  dissolving  crystals  and  helps  in  mechanical
expulsion of  stones  and  improve  the  renal  function  by removing  the  waste  product  and
decrease  oxalate  excretion  by interfering with  metabolism.  Results  of  this  study indicate
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Boerhaavia diffusa lin aposses antiurolithiatic that possibly mediated through diuretic and
hypo-oxaluric effects.[97]
Mahesh, A.R, et al., (2012) Had conducted a detailed study on Boerhaavia diffusa for it is
medicinal  importance.  Various phytochemical,  pharmacological,  experimental  and clinical
investigations are done on  Boerhaavia diffusa.  This include evidence based over view of
pharmacological, phytochemical properties of aerial parts & the roots of Boerhaavia diffusa,
which may be helpful to establish a standard natural drug for further studies.[98]
Meena,  A.K,  et  al.,  (2010) Investigated  the  standardized  and  phytochemically evaluated
aqueous and hydroalcoholic extracts of  Boerhaavia diffusa.  It  involves pharmacognostical
examination of morphological and microscopical characters and phytochemical investigation
of  Boerhaavia  diffusa  including  determination  of  loss  on  drying,  ash  values,  TLC  and
extractive  values.  The  qualitative chemical  examination revealed the presence of  various
phytoconstituents  like  carbohydrate,  saponins,  phenolic  compound  and  mucilage  in  the
extract .[99]
Babita  Aqrawal,et  al.,  (2011) Have  Investigated  a  review  on  it  is  phytochemical  and
pharmacological profile  Phytochemical studies had shown the presence of rich source of
alkaloids,  steroids  and  flavones.  Pharmacological  research  explains  hepatoprotective,
diuretic,  anti-inflammatory,  anti-stress  and immunomodulation anti  fertility,  antimicrobial,
antiviral, and insecticidal activities.  In  conclusion  Boerhaavia diffusa contain biologically
active compounds that may serve as candidate for new drugs in the treatment and prevention
of human livestock diseases.[100]
Goyal.B.M et al., (2010) Analyzed an overview of pharmacological potential of Boerhaavia
diffusa. It  covers various physiology, pathology of disease and their therapies. This article
includes evidence based information regarding pharmacological activity of this plant. It has
many ethanol botanical users and is medicinally used in the traditional Ayurvedic  system.[101]
Bhavin,  A,  et  al.,  (2013) Investigated  the  effect  of  hydro  alcoholic  extract  of  roots  of
Boerhaavia  diffusa in  experimental  Beningn  prostatic  hyperplasia  in  rats.  Body  weight,
prostate  weight,  bladder  weight  and  serum  testosterone  were  measured  and  histological
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studies were carried out. The result suggested that treatment with  Boerhaavia diffusa may
improve symptoms of disease and inhibit the increased prostrate sign. Invitro study implies
that  herbal  extract  had a beneficial  effect  on prostatic  smooth muscles  which relieve the
urinary symptom and disease. [102]
Krishna murti, et al., (2001) evaluated antidiabetic activity of ethanolic extract of roots of
Boerhaavia diffusa against  streptozocin   induced experimental  rats.  Blood glucose level
were determined on 0, 7th, 14, & 21st day after oral administration. The effect of ethanolic
extract of  B.diffusa on serum lipid profile like total cholesterol, triglycerides, LDL, VLDL,
HDL  were  also  measured  in  diabetic  and  non-diabetic  rats.  The  ethanolic  extract  of
Boerhaavia diffusa was found to reduce blood sugar level in streptozocin induced diabetic
rats. There was significant reduction in total cholesterol, LDL, VLDL, & improvement in
HDL cholesterol  in  diabetic  rats.  The  results  indicated  that  Boerhaavia  diffusa possess
hypoglycemic & anti-hyperlipidemic effect. [103]
Ajmire.  P.V, etal.,  (2011) Had conducted study of alcoholic & aqueous extract of whole
plant  of  Boerhaavia  diffusa against  DMNO  induced  liver  cirrhosis  in  rat’s  model.  The
activity  was  assessed  using  ILS,  histopathological  studies  of  liver,  biochemical
&heamatological  studies.  EEBD & AEBD shows significant  increase  in  survival  time,  a
decrease  in  cirrhotic  nodules.  The  biochemical  &heamatological  parameter  were  also
corrected by EEBD & AEBD in DMN induced rats. However out of these two extract, EEBD
shows maximum anti cirrhotic effect than AEBD. [104]
Venkatesh. P, et al., (2010) Evaluated analgesic & antipyretic activity of various doses of
alcoholic extracts of stem & leaves of Boerhaavia diffusa & leaves of Anisochiluscarnosus.
Tail immersion method & Hot plate in mice were studied for analgesic activity. Alcoholic
extract of Boerhaavia diffusa had shown significant analgesic & antipyretic activity. [105]
Mohammed Khalid, et al., (2012) Had studied pharmacological evaluation and qualitative
analysis of  Boerhaavia diffusa L.  root.  Various parameters  like macroscopic,  microscopy,
fluorescence analysis as well as extraction value and qualitative phytochemical screening of
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different extraction were studied. The major components of extractions like total phenolic,
total flavonoids were also estimated. [106]
Venkatesh. P, et al.,  (2012) evaluated a study on alcoholic extract of stem and leaves of
Boerhaavia diffusa and leaves of Anisochiluscarnosus on CCl4 induced hepatotoxicity in rats.
Different dose levels administered. Biochemical parameters of liver like SGOT, SGPT, serum
alkaline phosphatase, total and direct serum bilirubin were determined. It was concluded that
the alcoholic extract  of AEBD and AEAC possess hepato protective activity against ccl4
induced hepatotoxicity in rats. [107]
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AIM OF THE STUDY:
         The  present  study  was  undertaken  to  find  out  the  effect  of  the  potential
nephroprotective  effect  of  Boherhavia  diffusa  and  their  effects  on  cisplatin  induced
nephrotoxicity in wistar rats.
Plants have played a weighty role in maintaining human health and improving the
quality  of  human  life  for  thousands  of  years  and  have  several  precious  components  of
medicines, seasonings, beverages, cosmetics and dyes. Herbal medicines are based on the
premise that plants contain natural substances that can promote health and alleviate illness. In
recent times, focus on plant research has increased all over the world and large evidence has
collected to show immense potential of medicinal plants used in various traditional systems.
Today we are witnessing a great deal of public interest in the use of herbal remedies.
Many western  drugs  had  their  origin  in  plant  extract.  There  are  many herbs,  which  are
preponderantly used to treat cardiovascular problems, liver disorders, central nervous system,
digestive and metabolic disorders. Given their potential to generate significant therapeutic
effect,  they can be useful  as  drug or  supplement  in  the treatment,  management  of many
diseases.  Herbal  drug  or  medicinal  plants,  their  extracts  and  isolated  compounds  have
demonstrated spectrum of biological activities. Such have been used and continued to be
used as medicine in folk–fore or food supplement for various disorders. 
In our country, so many plant preparations are used for the treatment of disease. Only
limited  number  of  institutions  carries  out  these  research  studies.  Still
there are a number of plants that have not been screened and mostly used by tribals.
 
The present investigation was undertaken to study the effect of  Boherhavia diffusa on
changes  in  kidney parameters  such  as  Blood urea  nitrogen,  serum creatinine,  urea and  anti-
oxidant enzymes in cisplatin-induced nephrotoxicity in rats. The effects produced by this plant
extract on different parameters were compared with silymarin.
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PLAN OF WORK
• Collection of plant material (Boherhaavia diffusa) and preparation of plant extracts.
• Evaluation of Nephroprotective activity Boherhaavia diffusa and their effects on Kidney,
anti-oxidant enzymes.
• Selection, grouping and acclimatization of the animals.
• Induction of nephrotoxicity in rats by cisplatin.
• Treatment protocol.
• Evaluation of serum parameters and kidney enzymes.
• Histopathological examinations of kidney rats.
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PLANT PROFILE
Scientific Name       :   Boerhaavia diffusa linn. Syn. B. repens; B. repens var. diffusa.
Family                     :    Nyctaginaceae.
Family Name          :    Hog weed, Horse Purslane.
Taxonomical classification:
Kingdom                :         Plantae.
Family                    :         Nyctaginaceae.
Division                  :         Magnoliophyta.
Class        :          Magnoliopsida.
Order                      :          Caryophyllales.
Genus                     :          Boerhaavia.
Species                   :          B.diffusa.
Common Names:
Raktapunarnava,  Shothaghni,  Kathillaka,  Kshudra,  Varshabhu,  Raktapushpa,  Varshaketu,
Shilatika.
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Vernacular Names: [108]
Bengali                  :           Raktapunarnava.
English                  :           Horse Purslene, Hog Weed.
Hindi                     :           Gadapurna, Lalpunarnava.
Kannada                :           Sanadika, Kommeberu, Komma.
Malayalam            :           ChuvannaTazhutawa.
Tamil                    :           Mukurattai (Shihappu).
Telugu                  :           Atikamamidi, Erragalijeru.
GEOGRAPHICAL DISTRIBUTION:
Boerhaavia diffusa is also indigenous to India; it is found throughout the warmer parts of
the country up to an altitude of 2000 m in the Himalayan region. The genus  Boerhaavia has
several species, and is distributed in the tropical, subtropical, and temperate regions of the world.
[109]
 It is found in Australia, China, Pakistan, Sudan, Sri Lanka, Egypt, South Africa, USA and in
several countries of the Middle East. Out of the 40 species of this genus, 6 species are found in
India – B. diffusa, B. chinensis, B. erecta, B. repens, B.rependa, and B. rubicund.
ORIGIN AND HABITAT: 
Boerhaavia diffusa
 is a perennial creeping weed, prostrate or ascending herb, up to 1 m
long or more, having this is found throughout India. It grows up to an altitude of 70 centimeters
especially during the rainy season. It  has a large root system and produces yellow and white
flowers. It can be found in many tropical and warm-climate countries. [110]
USEFUL PARTS:        
Root, leaves & seeds, stem, flowers, fruits.
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DESCRIPTION: 
Boerhaavia diffusa is a perennial creeping weed, prostrate or ascending herb, up to 1 m
long or more, having spreading branches.
The roots  are very variable diffusely branched low spreading or  creeping herbaceous
perennial with an elongated fusiform or tapering tap root. The roots are stout and fusiform with a
woody.
The  stems  are  numerous;  1-2  m  long  &  the  stem is  prostrate,  woody or  succulent,
cylindrical, often purplish, hairy, and thickened at the nodes.
Leaves are simple, thick, fleshy and hairy arranged in unequal pairs, green and glabrous.
The shape of the leaves varies considerably ovate oblong, round or subcordate at the base and
smooth above.  The leaves are simple, opposite, short petiolate, exstipulate, unequal in each pair,
2.5-5 cm long by 1-4.5  cm wide,  oblong or  suborbicular,  acute,  obtuse or  rounded at  apex,
cordate rounded or truncate at  base,  entire or wavy along the margin, subfleshy, glabrous or
sparingly hairy above, silvery white beneath, petioles 0.7-3 cm long, slender, deeply grooved
above.
The flowers are small, regular, sessile or subsessile, pale rose to pink, in irregular clusters
of 4-10, small umbels on extra axillary peduncles. 
The fruits are very small, one seeded and enclosed in persistent lower half the perianth.
The perianth is covered with sticky glandular hairs. 
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Table.No:1
Part Boerhaavia diffusa
Plant A perennial herb from a fusiform root
Leaves Opposite or sub-opposite,  two of  a  node unequal,  broadly ovate or sub-
orbicular, obtuse to rounded or sub-cordate at the base.
Stem Prostrate,  decumbent  or  ascending,  4-10  cm  long,  rather  slender,
divaricately branched
Flowers In  pendunculate,  glomerulate  clusters  arranged  in  slender,  long  stalked,
axillary or terminal corymbs
Fruit Ovoid or sub-ellipsoid, rounded above, slightly cuneate, below, broadly and
bluntly 5-ribbed, very glandular throughout
Flowering and
Fruiting
Throughout the year in Indian conditions
Phytochemicals:
Boerhaavia  diffusa  contains  a  large  number  of  phytoconstituents,  namely  flavonoids
(Pandey et al., 2005), alkaloids, steroids, triterpenoids, lipids, lignins, carbohydrates proteins and
glycoproteins (Surange and Pandse1972).
• Plant  also  includes  a  series  of  rotenoids  boeravinones  from  roots  of  the  plant  viz.,
Boeravinone (A-F) [111-118]
• Punarnavoside,  a  phenolic  glycoside,  is  reportedly  present  in  roots.[119-121] C-methyl
flavone also has been isolated from Boerhaavia diffusa roots.
• Two known lignans viz.,liriodendrin and syringaresinol mono-β-D-glycoside isolated.[122]
• Presence of  a  purine nucleoside hypoxanthine 9-L-arabinose  ,dihydroisofuroxanthone-
borhavine , phytosterols,have been isolated from the plant. 
• It  contains  about  0.04  %  of  alkaloids  known  as  punarnavine  and  punernavoside  an
antifibrinolytic agent.
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•
It also contains
 about 6 % of potassium nitrate an oily substance and ursolic acid.[123]
• The seeds of this plant contain fatty acids and allantoin and the roots contain alkaloids.[124]
The green stalk of the plant has also been reported to contain boerhavin and boerhavic
acid.
Pharmacological and Clinical properties of B. diffusa
Various parts of B. diffusa are used for the treatment of numerous disorders in different
parts of India. The root, leaves, aerial parts or the whole plant of B. diffusa have been employed
for the treatment of various disorders in the Ayurvedic herbal medicine. The pharmacological
studies have demonstrated that the roots of B. diffusa exhibit a wide range of properties such as
hepatoprotectant, anticonvulsant activity, immunomodulatory activity, It is clinically proved as a
useful and safe drug in the patient of nephritic syndrome & cancer chemopreventive property
against  papillomagenesis.  potent  antibacterial  activity,  diuretic,  anti-inflammatory,
antifibrinolytic,  antibacterial,  antistress  agent,  antihepatotoxic,  anthelmintic  febrifuge,
antileprosy, anti-asthmatic, antiscabies, and anti-urethritis, and antinematodal activity .
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Chart. No:2 pharmacological and clinical properties of Boerhaavia diffusa.
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PHYTOCHEMICAL AND QUALITATIVE ANALYSIS
EXTRACTION METHODS:
Whole plant of Boerhaavia diffusa were collected from Tamilnadu, kerala forest,
shed dried for a week in a shadow and blended to coarse powder.
About 500gm of dried fine powder of  Boerhaavia diffusa  were soaked in the
extractor and macerated for 30 hrs with petroleum ether .There it is reflexed successfully with
chloroform, after that it is extracted with alcohol and water by continuous hot percolation
method using soxhlet apparatus for 40 hrs separately. Hydro alcoholic extracted was filtered
and  concentrated  in  vacuum using  rotary  flask  evaporator  under  reduced  pressure  .After
concentration hydro alcoholic extract of Boerhaavia diffusa given brownish residue stored in
air  tight  container  were  subjected  to  qualitative  test  for  identification  of  various  plant
constituents.  
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Dried whole plant of Boerhaavia diffusa material extracted by soxhlet method
Marc-I
Chart. No: 3  Extraction procedure.
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Marc-I Extracted with petroleum
ether (30 hrs)
Extracted with chloroform
(40 hrs)
Extracted with water (30%) + Ethanol
(70%)
(40 hrs) Marc-II
Brownish colour  Residue
Nephrotoxicity activity
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PHYTOCHEMICAL INVESTIGATION OF EXTRACTS OF
Boerhaavia diffusa Linn.
All the extracts of leaf of  Boerhaavia diffusa  linn were subjected to various tests  for
identification of constituents.
1) Detection of Carbohydrates  :
Small quantities of ethanolic and aqueous extract were dissolved in distilled water
separately and filtered. The filtrates were taken for the various tests to detect the absence of
carbohydrates. Absence of carbohydrate in Boerhaavia diffusa.
A. Molisch’s Test:
The filtrates were treated with 2-3 drops of 1% alcoholic  - napthol and 2 ml.  of
concentrated sulphuric acid was added along the sides of the test tube. A brown ring was
observed. Ethanolic Boerhaavia diffusa plant extract showed the absence of sugar.
B. Fehling’s Test:
    Small portion of the filtrates were treated with equal volume of Fehling’s solution
A and  B and  then  heated.  A brick  red  precipitate  formed  in  alcoholic  plant  extract  of
Boerhaavia diffusa show absence of reducing sugar.
C. Benedict’s Test:
    Small  portion  of  the  filtrates  were  treated  with  equal  volume  of  Benedict’s
reagent. A yellow precipitate was formed in alcoholic extract Boerhaavia diffusa indicating
the absence of reducing sugar
D. Barfoed’s Test:
     Small portion of the both the plant extract was treated with Barfoed’s reagent.  Red
precipitate was not formed in the ethanolic plant extract Boerhaavia diffusa.
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     E. Test for Starch:
A small amount of the  Boerhaavia diffusa ethanolic plant extract was treated with
dilute iodine solution. No bluish black colour was observed in the both the plant extracts
showing the absence of starch.
2) Tests for Gums and Mucilage’s:
Alcoholic precipitation and Molisch’s test.
 The, Boerhaavia diffusa  plant extract was treated with absolute alcohol, stirred and
filtered. The filtrate was dried and examined for its swelling properties. The extracts were
answered for the presence of gums and mucilage.     
3) Test for Proteins and Amino Acids:
   Small quantities of alcoholic extract was dissolved in few ml of distilled water
and subjected to Ninhydrin test, Xanthoprotein test, test with tannic acid and heavy metals.
 A.  Ninhydrin Test:
 Ethanolic extract of the both the plants were treated with ninhydrin reagent (0.1%
solution) and boiled. Purple colour was observed indicating the presence of protein.
B. Biuret Test:
      To a portion of the above prepared extracts, equal volumes of 5% w/v sodium
hydroxide and 4 drops of 1% w/v copper sulphate solution were added. Violet colour was
formed, indicating the presence of protein in the extract.
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C. Millon’s test of cole’s mercuric nitrite test:
     To the above-prepared extracts, millon’s reagent was added. White precipitate was
formed, showing the presence of protein in the extract.
D. Xanthoprotein Test:
            To 3 ml of the above-prepared extracts, 1 ml of the concentrated nitric acid was
added, boiled for one minute, cooled and concentrated ammonia was added till alkaline. An
orange colour was not formed, showing the presence of protein in the extracts.
4) Test for Fixed Oils and Fats:
A. Spot Test:
            A small quantity of various extracts was pressed between two filter papers. Oil
stains were observed with the extracts indicating the presence of fixed oils and fats.
  B. Saponification Test:
       Few drops of 0.5 N alcoholic potassium hydroxide was added various extracts
along with of few drops of phenolphthalein. The mixture was heated on a water bath for
one hour. Soap was formed with the extracts indicating the presence of fixed oils and fats.
5) Test for Alkaloids:
        Small amount of the solvent free ethanolic and aqueous extracts were separately
stirred with a few ml of dilute HCl and filtered. The filtrates were tested with various
alcoholic reagents.
A. Mayer’s test :
        To the small quantities of the extracts, Mayer’s reagent was added. Presence of
cream-colored precipitate indicates the presence of alkaloids in both the extracts.
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B. Dragendorff’s Test:
             To small quantity of extracts, Dragendorff’s reagent was added. Presence of
orange brown precipitate indicates the presence of alkaloids in both plant extracts.
C. Wagner’s Test:
To  small  quantity  of  the  extracts,  Wagner’s  reagent  was  added.  Presence  of
reddish brown precipitate, indicate the presence of alkaloids in Boerhaavia diffusa extract
D. Hager’s Test:
To small quantity of the extracts, Hager’s reagent was added. Presence of yellow
precipitate, indicate the presence of alkaloids in Boerhaavia diffusa extract.
6) Tests for Glycosides:
A small  amount of the different  extracts  were dissolved separately in 5 ml  of
distilled  water  and  filtered.  Another  portion  of  the  extracts  were  hydrolyzed  with
hydrochloric acid for one hour on a water bath and hydrolyzate was subjected to Legal’s,
Baljet’s,  Borntrager’s,  Keller-Killani’s  tests  and  for  the  presence  of  cyanogenetic
glycosides.
A. Legal’s Test:
To the hydrolyzate, 1 ml of pyridine and a few drops of sodium nitroprusside
solution was added and then made alkaline with sodium hydroxide solution. Pink colour
was observed in Boerhaavia diffusa extract.
B. Baljet’s Test:
To a section of plant extract, sodium picrate solution was added. Yellowish orange
colour was observed in Boerhaavia diffusa extract.        
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C. Borntrager’s Test:
   Hydrolyzed  was  treated  with  chloroform  and  the  chloroform  layer  was
separated. To this, equal quantity of dilute ammonia solution was added. Pink colour was
not observed in the ammonical  layer of chloroform and both the extracts showed the
absence of glycosides.
   D. Test for Deoxy Sugar (Keller-Killani Test):
   To the different extracts 10 ml of 70% alcohol were added, boiled on a water
bath, filtered. The filtrates were diluted with 1 ml of distilled water; 1ml of strong lead
acetate solution was added and filtered. The filtrates were extracted with an equal volume
of chloroform. The chloroform layer was pipetted out and evaporated to dryness. The
residue obtained was dissolved in 3 ml of 3.5% of ferric chloride in glacial acetic acid,
left for one minute and then transferred to a test tube. To the side of the test tube, 1.5 ml
of sulphuric acid was added carefully, which formed a separate layer at the bottom and
kept for few minutes.
Blue colour  at  the interface and pale green colour in the upper layer  was not
observed in any of the extracts indicating the absence of cardiac glycoside.
7) Test for Phytosterols:
   Small quantities of the various extract were dissolved in the 5 ml of chloroform
separately.  Then  these  chloroform  solutions  were  subjected  to  Libermann’s  test,
Libermann-Burchard’s test, Salkowski’s test.
A. Libermann-Burchard’s Test:
       The residue was dissolved in chloroform. To this Libermann-Burchard’s reagent
was added.  Green  colour  was  produced  in  both the extract  indicating the presence of
phytosterols.
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B. Salkowski’s test:
             A few drops of concentrated sulphuric acid were added to chloroform solution.
The  lower  layer  of  the  solution  turned  brownish  red  colour  with  both  the  extracts
indicating the presence of phytosterols.
8) Test for Flavanoids:
    The different extracts were separately dissolved in ethanol and then subjected to
the following tests.
A. Ferric chloride Tests:
   To a small quantity of the ethanolic extract, few drops of neutral ferric chloride
were added. Blackish red colour was observed in Boerhaavia diffusa extract indicating the
presence of flavonoids.
B. Shinoda’s test:
 A small quantity of the extract was dissolved in alcohol and to this magnesium
metal followed by concentrated   hydrochloric acid, was added drop wise and heated.  A
magenta colour was produced in  Boerhaavia diffusa  extract indicating the presence of
flavonoids.
C. Flavones:
1. With sodium hydroxide solution, the extract gave yellow colour.
2. Ethanolic extract gave orange colour with concentrated sulphuric acid.
.
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9) TEST FOR TANNINS:
   The extracts were dissolved in water and filtered. The filtrates were treated with
various reagents. 
A. Ferric chloride test:
   Few ml of the filtrates were treated with 5% ferric chloride solution. A bluish black
colour was observed indicating the presence of tannins in both the extracts.
B. Reaction with lead acetate:
Few ml of the filtrates were treated with lead acetate solution. White precipitates
were produced in Boerhaavia diffusa extract indicating the presence of tannins.
C. Gelatin Test:
The extract were dissolved separately in minimum amount of water and filtered.
To the filtrate, add 1 ml of 1 % solution of gelatin. Both the extract did not produce any
white precipitate.
.
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QUALITATIVE CHEMICAL ANALYSIS OF ETHANOLIC EXTRACT OF 
Boerhaavia diffusa Linn.   
Table.No:2
SI.NO Test for plant constituents Boerhaavia
diffusa Linn.
Test for alkaloids
1    a. Mayer's Test +
   b. Dragendorff's Test +
   c. Wagner's Test +
   d. Hager's Test +
Test for Glycosides
   a. Legal's Test +
2    b. Baljet's Test +
   c. Borntrager's Test +
   d. Keller-Killani's Test +
Test for Flavanoids
3    a. Ferric chloride Test +
   b. Shinoda's Test +
   c. Fluorescence Test +
   d. Reaction with alkali and acid +
Test for Tannins and Phenolic Compounds
4   a.  5% Ferric chloride solution test +
  b.  Reaction with lead acetate +
  c.  Gelatin test _
Test for Proteins and amino acids
6
   a. Ninhydrin Test +
   b. Biuret Test +
   c. Millon's test or Cole's Mercuric Nitrate
test
+
   d. Xanthoprotein test +
Test for Carbohydrates
7   a. Molisch's test -
  b. Fehling’s test -
  c. Benedict's test -
  d. Barfoed's test -
  e. Test for Starch -
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Test for Gums and Mucilage
8 Alcoholic precipitation and Molisch's test +
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EXPERIMENTAL MODELS
For the study of  Nephroprotective  and antioxidant  activity an animal  model  was  added that
would satisfy the following conditions. 
 The animal should develop nephrotoxicity rapidly and reproducibly.  
 Pathological changes in the   site   of induction   should   result   from kidney damage.  
 The  symptoms  should be ameliorated  or   prevented  by  a  drug  treatment  effective  in
human  beings .  
 The drug tested should be administered orally. 
 Drug  dosage  approximate  the  optimum  therapeutic  range  for  human,  scaled  the
test  animal  weight.  
LABORATORY ANIMAL MODELS
Induction of nephro toxicity and free radicals in animal model:
The  invivo mechanisms of cisplatin nephrotoxicity are complex and involve oxidative
stress,  inflammation  and  apoptosis.[125] Apoptotic  markers  include  proteins  from  both  pro-
apoptotic and anti-apoptotic elements.  Bak is a pro-apoptotic member of the Bcl-2 family of
apoptotic proteins. The Bcl-2 related proteins interact with one another through the formation of
homo and heterodimers. 
The susceptibility of cells to apoptotic stimuli is thought to be controlled by the relative
ratios of the different Bcl-2 family proteins. This protein localizes to mitochondria and functions
to induce apoptosis. It interacts with and accelerates the opening of the mitochondrial voltage-
dependent  anion  channel,  which  leads  to  a  loss  in  membrane  potential  and  the  release  of
cytochrome c.[126]
 MATERIALS AND METHODS:
Animals
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In-house laboratory bred 6 week old wistar rats were selected for the study. Animals were
maintained under controlled temperature at 20±20c and relative humidity of 50-60% with an
alternating 12hr light/ dark cycle. Food and water provided ad libitum. The research work was
approved  by  Institutional  animal  Ethical  Committee.(IAEC/KMCP/61.REG  NO:261225056
M.PHARMA/2012-2014.)
Experimental protocol
Rats were divided into 5 groups of 6 each. 
Group 1: Served as Normal Control, which received 10ml/kg of normal saline. 
Group 2: Served as Toxic control, which received Cisplatin (7.5mg/kg b.w, i.p) on day one. 
Group 3: Served as positive control  which received Cisplatin (5mg/kg b.w, i.p) on day one
followed by silymarin (50mg/kg b.w, orally) for 10 days. 
Group 4: Served as Treatment group, which received Cisplatin (5mg/kg b.w,i.p) single dose on
the day one followed by HAEBD at a dose of 200mg/kg orally for 10 days. 
Group 5: Served as Treatment group, which received Cisplatin (5mg/kg b.w,i.p) single dose on
the  day  one  followed  by  HAEBD  at  a  dose  of  400mg/kg  orally  for  10  days.  
.   
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BIOCHEMICAL ASSAY
On day 11 cisplatin injection was administered to all groups except normal control. After
72 hrs of cisplatin injection animals were sacrificed using ether anesthesia; blood samples were
collected by retro orbital puncture for measuring BUN,Scr,Alp and urea. Kidneys were quickly
removed and washed with ice –cold normal saline and homogenates (10%w/v) were prepared in
PBS.A part of the homogenate was used for the estimation of glutathione (GSH) and lipid per
oxidation.  The remaining homogenate was centrifuged at  5000 rpm for 10 min at  40C; after
removal  of  the  cell  debris,  the  supernatant  was  used  for  the  assay of  superoxide  dismutase
(SOD), catalase (CAT) and glutathione peroxidase (GPX).
Serum creatinine was assayed according to Jaffe’s kinetic method,[127] Blood urea nitrogen
and  urea  was  assayed  according  to  Berthelot  end  point  assay  [128]  and  Alkaline  phosphatase
according to pNPP- AMP (IFCC), kinetic assay [129 using Autospan kits. 
The GSH level was measured colorimetrically using 5, 5'- Dithio.bis (2 - nitrobenzoic
acid) (DTNB) as the substrate. The concentrations of malondialdehyde (MDA) as indices of lipid
peroxidation were assessed. The SOD activity was determined by the Nitro blue tetrazolium
(NBT) reduction method. The GPx activity was determined by the method. The CAT activity was
determined from the rate of decomposition of H2 O2, method. 
Histopathological analysis: 
Rats were euthanized under light anaesthesia with ether and the kidneys were dissected
out. Kidneys were perfused with buffered saline to remove blood and then the left kidney was
fixed in 10% neutralized buffered formalin for histopathology studies. Histopathological studies
were done at Apollo diagnostics, Madurai. 
Statistical analysis:
The results  were expressed as  Mean± S.E.M and analyzed with  one way analysis  of
variance  between  the  two  groups  and  followed  by  newmann  keuls  multiple  range  tests.
Probability values p≤ 0.05 were considered significant.
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Effects of ethanolic extract of Boerhaavia diffusa on renal malondialdehyde, glutathione, 
catalase, and superoxidedismutase, glutathione peroxidase (gpx) activities in treated rats.
 TABLE NO: 3
Group
No.
TREATMENT
DOSE
(mg/Kg)
MDAu/
mg
Protein
GSH 
u/mg
Protein
CAT u/mg
protein
SODu/m
g
Protein
GPX u/mg
Protein 
I Normal control
10ml/kg
normal saline 2.11±0.1
8
15.15±0.
40
55.30±1.4
0
15.30±0.
40
23.20±0.9
0
II Toxic control
7.5mg/kg
Cisplatin
induced
              
4.90±0.4
2*a
           
4.40±0.2
0*a
               
10.45±0.3
5*a
              
6.15±0.1
6*a
              
10.10±0.3
2*a
III Positive control
50mg/kg
Silymarin
              
2.85±0.2
4*b
              
13.40±0.
36*b
              
40.90±0.7
5*b
              
13.05±0.
32*b
             
20.15±0.5
6*b
IV Treatment
control
HAEBD
200 mg/kg
              
3.65±0.3
2*b
             
10.52±0.
26*b
             
29.45±0.4
5*b
              
10.90±0.
25*b
              
16.40±0.6
2*b
V Treatment
control
HAEBD
400mg/kg
              
3.05±0.2
6*b
              
11.25±0.
30*b
              
34.50±0.6
8*b
              
12.60±0.
28*b
              
18.25±0.6
8*b
 Values are expressed as Mean ± SEM.
 Values are found out by using one way ANOVA followed by Newmann kevl’s multiple range tests.
 *a – values are significantly different from Normal control at P< 0.01.
 *b – values are significantly different from Toxic control (G2) at p< 0.01. 
Effect of HAEBD on serum creatinine, blood urea nitrogen &alkaline
phosphatase                                                             
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       Table :4
Group.
No.
TREATMENT
DOSE
(mg/Kg)
Serum
creatinine
Blood urea
nitrogen
mg/dl 
Alkaline
phosphate
mg/dl
Urea
mg/dl
I
Normal control
10ml/kg
normal saline
0.05±0.0
2
18.55±0.5
8
155.60±0.7
5
17.2±0.4
0
II Toxic control
7.5mg/kg
Cisplatin induced
             
1.310±0.
05*a
               
104.30±5.
55*a
             
345.20±1.5
8*a
           
78.6±1.6
5*a
III Positive control
50mg/kg
Silymarin
            
0.796±0.
03*b
             
38.75±1.2
8*b
             
186.75±0.9
0*b
           
24.5±0.4
8*b
IV Treatment control
HAEBD
200 mg/kg
            
0.870±0.
04*b
            
56.10±2.0
5*b
             
248.60±1.0
5*b
 
46.4±0.5
6*b
V Treatment control
HAEBD
400mg/kg
           
0.805±0.
03*b
            
44.25±1.6
0*b
            
210.45±0.9
6*b
        
38.2±0.5
0*b
 Values are expressed as Mean ± SEM.
 Values are found out by using one way ANOVA followed by Newmannkeul’s multiple range
tests.
 *a – values are significantly different from Normal control at P< 0.01.
 *b – values are significantly different from Toxic control (G2) at p< 0.01. 
Figure.No: 10
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SERUM LEVELS OF MDA U/G PROTEIN VALUES OF MEANS OF 6 RATS IN EACH 
GROUP.
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Figure. No: 11
SERUM LEVELS OF GSH U/G VALUES OF MEANS OF 6 RATS IN EACH GROUP.  
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Figure. No: 12
SERUM LEVELS OF CAT U/G VALUES OF MEANS OF 6 RATS IN EACH GROUP.
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Figure. No: 13
SERUM LEVELS OF SOD U/G VALUES OF MEANS OF 6  RATS  IN EACH  GROUP
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Figure. No: 14
SERUM LEVELS OF SOD U/G VALUES OF MEANS OF 5  RATS  IN EACH  GROUP.
EFFECT OF HAEBD ON SERUM CREATININE ,BLOOD UREA
NITROGEN &ALKALINE PHOSPHATASE 
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Figure. No: 15
SERUM  CREATININEVALUES OF MEANS OF 6 RATS IN EACH GROUP.
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Figure. No: 16
BLOOD UREA NITROGEN  VALUES  OF  MEANS  OF 6 RATS IN EACH GROUP.
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Figure no: 17
ALKALINE  PHOSPHATE VALUES OF MEANS OF 6 RATS IN EACH GROUP.
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Figure. No: 18
UREA VALUES OF MEANS OF 6 RATS IN EACH GROUP.
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            HISTOPATHOLOGICAL STUDIES 
    Figure. No: 19
          
Kidney Section of GP1 (Normal Control) Rats
There was no glomerular congestion with any evidence of edema, heamorrhage,
inflammation or tubular necrosis.
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Figure. No: 20
        
           
Kidney Section of GP2 (cisplatin induced toxic Control) Rats
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Figure. No: 21
Kidney Section of GP3(silymarin 50mg/kg/rat)
Shows mild renal tissue damage .No evidence of congestion.
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Figure. No: 22
Kidney Section of GP4( Boerhaavia diffusa extract 200mg/kg/rat)
Shows mild renal tissue damage.No evidence of heamorrhage,glomerular atrophy
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Figure. No: 23
Kidney Section of GP5 (Boerhaavia diffusa 400mg/kg)
Shows mild renal tissue damage.No evidence of heamorrhage,glomerular atrophy
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RESULTS AND DISCUSSION
Result:
In acute oral toxicity study the extract was found to be safe up to a dose of 2000
mg/kg.
In the present studies, the cisplatin treated animals showed a significant increase in blood
urea, blood urea nitrogen and serum creatinine. As shown in [Table no:4] serum creatinine,
Blood urea nitrogen (BUN), and blood urea levels were significantly higher after 72 h
respectively, after administration of single dose of cisplatin when compared to the control
group. The pre-treatment with Hydro alcoholic extract  of  Boerhaavia diffusa (HAEBD)
p.o. significantly (P < 0.01) lowered the elevated serum urea creatinine, and Blood urea
nitrogen (BUN). When compared to the cisplatin group. The pre-treatment with silymarin
showed a marked decrease in concentrations of blood urea, serum creatinine, Blood urea
nitrogen and alkaline phosphatase.
Effects of HAEBD on renal oxidant/antioxidant status:
                In cisplatin treated group the activities of antioxidant enzymes like SOD, CAT
and GPx and levels of GSH were found to be significantly decreased with marked increase
in MDA as compared with control (P < 0.01). The pre-treatment of HAEBD and silymarin
was found to significantly elevate the decreased activities of SOD, CAT and GPx (P <
0.01).   The activities of renal SOD, CAT and GPx in the cisplatin treated, cisplatin plus
HAEBD and  cisplatin  plus  silymarin  administered  groups  were  given  in  [Table  no:3].
Administration of HAEBD and silymarin also inhibited the cisplatin-induced elevation in
the  MDA.  The  decrease  in  the  GSH  levels  in  renal  tissues  induced  by  cisplatin  was
prevented by the administration of HAEBD and silymarin (P < 0.01) [Table no:3]
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Effects of HAEBD on kidney histology:
Treatment  with  cisplatin  caused  a  marked  necrosis  in  proximal  tubules  and
degeneration of the tubular epithelial cells [Figure.No:23] The pre-treatment with HAEBD
and  silymarin  decreased  the  cisplatin  induced  tubular  necrosis  when  compared  with
cisplatin treated group.
Discussion:
   The impairment of kidney function by cisplatin is recognized as the main side
effect and he most important dose limiting factor associated with its clinical use.  Several
investigators [130,131] reported that the alterations induced by cisplatin in the kidney functions
were characterized by signs of injury, such as increase of products of lipid peroxidation
(LPO) and changes in GSH levels in kidney tissue, creatinine and urea levels in plasma.
  The renal antioxidant status, such as SOD, CAT, GPx activities, and reduced GSH
concentration are significantly decreased in the cisplatin treated group of animals compared
to the control group. The declined antioxidant status partially explains the mechanism of
nephrotoxicity  induced  by  cisplatin.  The  renal  accumulation  of  platinum and  covalent
binding of renal  protein may also play a role in the nephrotoxicity.[132,133]  In the present
study, increased serum creatinine and urea were observed in cisplatin treated rats may be
due  to  reduction  in  glomerular  filtration  rate.  The  impairment  in  kidney function  was
accompanied by an increase in MDA concentrations in kidney tissue. The above findings
were well-correlated with the renal histological results. These observations indicated that
cisplatin induced nephrotoxicity and the results are in accordance with previous findings.
The pre-treatment of HAEBD provides a significant protection against cisplatin-induced
nephrotoxicity with lowering the level  of plasma creatinine and blood urea in cisplatin
treated animals.
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       Decreased concentration of GSH increases the sensitivity of organs to oxidative
and chemical injury. The role of GSH, non-protein thiols in the cells, in the formation of
conjugates with electrophilic drug metabolites, most often formed by cytochrome P-450-
linked monooxygenase, is well-established. [134] Studies with a number of models show that
the metabolism of xenobiotics often produced GSH depletion.  Reduced renal  GSH can
markedly increase the toxicity of cisplatin. The depletion of GSH also seems to be a prime
factor  that  permits  lipid  peroxidation  in  the  cisplatin-treated  group.  Moreover,  the
protection of GSH is also by forming the substrate  for the GPx activity that  can react
directly with various aldehydes produced from the peroxidation of membrane lipids. The
enhanced  GPx  activity  could  partially  explain  the  protection  of  bio  membranes  from
oxidative attack.
Decreased  SOD  activity  could  cause  the  initiation  and  propagation  of  lipid
peroxidation in the cisplatin treated group. This may be either due to loss of copper and
zinc, essential for the activity of enzyme or due to ROS induced inactivation of enzyme
proteins. The decrease in activities of CAT and GPx could enhance the lipid peroxidation.
Thus, the levels of MDA, as a result of lipid peroxidation, were increased in the cisplatin-
treated animals. Although, the exact mechanism of cisplatin-induced nephrotoxicity is not
well-understood,  several  investigators  have  shown  that  cisplatin  nephrotoxicity  is
associated  with  LPO in  renal  tissue.  LPO is  ascribed  to  a  free  radical-mediated  chain
reaction that damages cell membranes, and inhibition of this process by HAEBD is mainly
attributed  to  the ability of  scavenger  free radicals.[135] In  the present  investigation,  pre-
treatment with HAEBD inhibited the increase in LPO induced by cisplatin in renal tissue,
indicating antioxidant activity of HAEBD.[136]
The  histopathological  evaluation of  the  kidney preparations  in  treatment  group  also
revealed a decreased cisplatin-induced tubular necrosis. Cisplatin-induced renal damage is
associated  with  increased  renal  vascular  resistance  and  histopathological  damage  to
proximal tubular cells. On the other hand, an increase in GSH levels in the renal tissue
indicates  that  pretreatment  with  HAEBD  was  due  to  oxidative  stress.  The  effects  of
HAEBD on cellular GSH may be due to antioxidant effects. The treatment with HAEBD
prevented the lipid peroxidation by enhancing the renal CAT, SOD and GPx activities.
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                                                                                              conclusion
Conclusion
In  conclusion,  it  was  shown  that  cisplatin  treatment  induced  renal  damage  and
pretreatment with hydro alcoholic extract of Boerhaavia diffusa (HAEBD) provided protective
effect  against  this  cisplatin-induced  nephrotoxicity.  However,  before  concluding  a  potential
usefulness of hydro alcoholic extract of Boerhaavia diffusa (HAEBD) as adjunct to the cisplatin
therapy, further clinical investigation is needed.
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